Target intelligence / Profile preview

Nuclear pore complex protein Nup214 (NUP214)

Target
NUP214
Molecular classification
Nucleoporin, Structural constituent of nuclear pore complex, FG-repeat-containing protein, Other
01

Overview

Nuclear pore complex protein Nup214 (NUP214) is a critical FG-repeat-containing nucleoporin localized to the cytoplasmic face of the nuclear pore complex in human cells. It plays an essential role in nucleocytoplasmic transport, serving as a docking site for receptor-mediated import and export of macromolecules, and is necessary for proper cell cycle progression and mRNA export. NUP214 is notable for its involvement in disease, particularly as part of the DEK-NUP214 fusion gene, which arises from a t(6;9) chromosomal translocation in certain leukemias[1][5]. The protein interacts with several transport factors including DDX19, CRM1, NXF1, and NXF2, participating in remodeling of messenger ribonucleoprotein particles (mRNPs) during their export from the nucleus to the cytoplasm[1][2][3]. Given its essential cellular functions and disease linkages, NUP214 is investigated as a prospective therapeutic target but poses significant challenges due to its fundamental cellular roles and potential toxicity upon inhibition[6].

Other names
CAINCANKIAA0023D9S46EN214214 kDa nucleoporinProtein CANNucleoporin Nup214CAN proteinputative oncogeneIIAE9nucleoporin 214kDa
02

Mechanism of action

Modulation of nucleocytoplasmic transport pathways; Potential disruption or targeting of protein-protein interactions (e.g., with DDX19, CRM1); Targeting oncogenic fusion products (e.g., DEK-NUP214 fusion in leukemia)

03

Biological functions

Nucleocytoplasmic transportCell cycle progressionmRNA export and remodelingDocking site for receptor-mediated import
04

Disease associations

Cancer (notably acute myeloid leukemia with t(6;9) translocation)Myelodysplastic syndromeEncephalopathy (Acute, infection-induced)Other
05

Safety considerations

Essential for basic cellular viability—global inhibition likely to impart toxicityStructural requirement for nuclear-cytoplasmic transport poses risk for off-target or systemic cell cycle disruptionPotential for broad effects on gene expression and mRNA export
06

Biomarkers

DEK-NUP214 fusion gene (biomarker for t(6;9) acute myeloid leukemia)

Beyond the preview

Go deeper on Nuclear pore complex protein Nup214 (NUP214).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nuclear pore complex protein Nup214 (NUP214).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call